Login

ADT CEO Jim DeVries Shares Insights on Recent Business Moves and Future Growth Strategies 00:10:00

Share On Facebook Share On Twitter

ADT President and CEO Jim DeVries

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Takes a low-volume high-conviction approach|Brad Svrluga,General Partner,Primary Venture Partners
00:10:00
Cliff Asness Discusses Market Strategies Amid Inflation and Recession Concerns | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Michael Mandelbaum on the Future of the Russia-Ukraine War|Michael Mandelbaum,Professor,Johns Hopkins University
00:10:00
Hillcrest Energy Partners with BC Hydro's Powertech for Advanced Grid Inverter Testing | James Bolen, the Chief Commercialization Officer of Hillcrest Energy Technologies
00:10:00
Condor Gold CEO Mark Child Announces Significant Progress and Potential Sale of La India Project in Nicaragua | Condor Gold CEO Mark Child
00:10:00
Alberta Energy Regulator Enhances Inspections for Tailings Dam Safety
00:10:00
Natural Resources: Transforming from Gold Explorer to Producer in Western Australia
00:10:00
Arrow Exploration Announces Milestone Horizontal Drilling at Tapir, Promising Significant Production Increase |Arrow Exploration Corp CEO Marshall Abbott
00:10:00
Culpeo Minerals Focuses on Systematic Exploration for Copper Resources in Chile | Max Tuesley, Managing Director , Culpeo Mineral Plc.
00:10:00
A-Mark Precious Metals CEO Greg Roberts Discusses Market Trends and Strategic Goals | Greg Roberts, CEO , A-Mark Precious Metals .
00:10:00
Steve Steinour, Chairman, President, and CEO of Huntington Bancshares, discusses the state of banking and lending on "Mad Money" with Jim Cramer.
00:10:00
Navigating Market Uncertainty: Risk Assessment and Long-Term Investment Strategies

© 2026 Nehu